We found for
Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

Key Considerations for Early Access Schemes for Single-Administration (One-Time) Therapies

Exploring the Financial Sustainability of Gene Therapies

The Promise of Gene Therapies: Are we Ready?

Personalised Medicine: is it an Oil-Rush or Oil-Spill?

Early Experience with Health Technology Assessment of Gene Therapies in the United States: Pricing and Paying for Cures

Gene Therapy: Understanding the Science, Assessing the Evidence, and Paying for Value

Exploring the Assessment and Appraisal of Regenerative Medicines and Cell Therapy Products: Is the NICE Approach Fit for Purpose?

Genomics, Healthcare and Public Policy
